| Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis (NCT01216891) | Research Foundation for Mental Hygiene, Inc. | 2010-10-01 |
| A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder (NCT01193153) | Janssen Scientific Affairs, LLC | 2010-09-01 |
| Effectiveness of Ziprasidone for Patients With Schizophrenia (NCT01198353) | Soonchunhyang University Hospital | 2010-09-01 |
| Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia (NCT01242371) | Sheppard Pratt Health System | 2010-08-01 |
| A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (NCT01143090) | Sumitomo Pharma America, Inc. | 2010-08-01 |
| Randomized Double Blind Placebo Control Study in Patients with Schizophrenia (NCT01602029) | Pakistan Institute of Living and Learning | 2010-08-01 |
| Reduction of Cardiovascular Risk in Severe Mental Illness (NCT01182012) | Consorci Hospitalari de Vic | 2010-08-01 |
| Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis (NCT01196286) | University of Arizona | 2010-06-01 |
| A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents (NCT01143077) | Sumitomo Pharma America, Inc. | 2010-06-01 |
| Nonconvulsive Electrotherapy: a Proof-of-concept Trial (NCT01065597) | University of Maryland, College Park | 2010-05-01 |
| Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia (NCT01324167) | Taipei Medical University WanFang Hospital | 2010-05-01 |
| Smoking Cessation for Veterans With Severe and Persistent Mental Illness (NCT00960375) | US Department of Veterans Affairs | 2010-04-01 |
| Database Registry for Neural Network Biomarkers in Psychosis (NCT01409109) | University of Texas Southwestern Medical Center | 2010-03-01 |
| Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia (NCT01093365) | Centre for Addiction and Mental Health | 2010-03-01 |
| Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis (NCT01570972) | University of Arizona | 2010-02-01 |
| Study of Vitamin D in the Severely Mentally Ill (NCT01169142) | Bronx Psychiatric Center | 2010-01-01 |
| Cannabis and Schizophrenia: Self-Medication and Agonist Treatment (NCT00946348) | Dartmouth-Hitchcock Medical Center | 2009-12-01 |
| Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia (NCT00728728) | VA Office of Research and Development | 2009-12-01 |
| Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia (NCT01029769) | Technical University of Munich | 2009-12-01 |
| Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography (NCT00942981) | National Institute of Mental Health (NIMH) | 2009-11-13 |
| Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression (NCT01028196) | AstraZeneca | 2009-11-01 |
| Oxytocin Treatment of Schizophrenia (NCT01028677) | University of North Carolina, Chapel Hill | 2009-11-01 |
| Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI) (NCT00817154) | Dartmouth-Hitchcock Medical Center | 2009-11-01 |
| Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study (NCT01269710) | University of North Carolina, Chapel Hill | 2009-10-01 |
| Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. (NCT00716755) | Centre for Addiction and Mental Health | 2009-10-01 |
| Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation (NCT00975611) | David C. Henderson, MD | 2009-10-01 |
| Lifestyle Modification for Weight Loss in Schizophrenia (NCT00990925) | Yale University | 2009-10-01 |
| Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI (NCT02334280) | Dartmouth-Hitchcock Medical Center | 2009-09-01 |
| Cognitive Remediation in Early Phase Psychosis (NCT01546467) | Oslo University Hospital | 2009-09-01 |
| Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia (NCT00864825) | Sheba Medical Center | 2009-08-01 |
| Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia (NCT00833976) | Massachusetts General Hospital | 2009-07-01 |
| Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER (NCT02075528) | Taipei City Hospital | 2009-07-01 |
| Extended Specialized Assertive Intervention for First Episode Psychosis (NCT00914238) | University of Copenhagen | 2009-07-01 |
| Vitamin D Supplementation in Psychiatric Illnesses (NCT01004354) | University of Massachusetts, Worcester | 2009-06-01 |
| Open-label Study of Curcumin C-3 Complex in Schizophrenia (NCT01875822) | Woodbury, Michel, M.D. | 2009-06-01 |
| Role of Anti-Inflammatory Agents in Patients With Schizophrenia (NCT00929955) | Pakistan Institute of Living and Learning | 2009-06-01 |
| Polypharmacy in Clozapine-resistant Schizophrenia (NCT00918021) | Niuvanniemi Hospital | 2009-06-01 |
| Biomarkers in Schizophrenia (NCT00817336) | Nathan Kline Institute for Psychiatric Research | 2009-06-01 |
| Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients (NCT01043250) | Samsung Medical Center | 2009-05-01 |
| A Shared Decision Making Training for Inpatients With Schizophrenia (NCT00885716) | Technical University of Munich | 2009-05-01 |
| Cognitive-Behavioral Therapy in Veterans With Schizophrenia (NCT00688259) | VA Office of Research and Development | 2009-04-01 |
| Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia (NCT00981526) | University of Massachusetts, Worcester | 2009-03-01 |
| Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia (NCT00588731) | Yale University | 2009-02-01 |
| 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study (NCT00818298) | Centre for Addiction and Mental Health | 2009-01-01 |
| Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment (NCT00789022) | Shalvata Mental Health Center | 2009-01-01 |
| Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia (NCT00793780) | Yale University | 2008-12-01 |
| Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia (NCT00825045) | Centre for Addiction and Mental Health | 2008-12-01 |
| Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy (NCT00791440) | New York State Psychiatric Institute | 2008-11-01 |
| Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects (NCT00734435) | Orexigen Therapeutics, Inc | 2008-09-01 |
| Artemisinin to Reduce The Symptoms of Schizophrenia (NCT00753506) | Sheppard Pratt Health System | 2008-08-01 |
| Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness (NCT00714818) | University of British Columbia | 2008-08-01 |
| The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels (NCT01385709) | Weill Medical College of Cornell University | 2008-08-01 |
| Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia (NCT00727103) | State University of New York - Upstate Medical University | 2008-07-01 |
| Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia (NCT00749970) | AstraZeneca | 2008-07-01 |
| Schizophrenic Patients in Integrated Care (NCT00681629) | AstraZeneca | 2008-07-01 |
| Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain (NCT00709202) | Nathan Kline Institute for Psychiatric Research | 2008-07-01 |
| Impact of Genetic Counseling for Individuals With Mental Illness (NCT00713804) | University of British Columbia | 2008-07-01 |
| Biomarker Study of Acamprosate in Schizophrenia (NCT00688324) | University of Maryland, Baltimore | 2008-06-01 |
| A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses (NCT00701753) | TheraGenetics Limited | 2008-05-01 |
| A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia (NCT00686400) | Martin-Luther-Universität Halle-Wittenberg | 2008-05-01 |
| Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia (NCT00645944) | Yale University | 2008-04-01 |
| Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia (NCT01915017) | The University of Texas Health Science Center at San Antonio | 2008-04-01 |
| Cardio Risk of Acute Schizophrenia Olanzapine Duke (NCT00672464) | Duke University | 2008-04-01 |
| Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia (NCT00641745) | Sumitomo Pharma America, Inc. | 2008-03-01 |
| Schizophrenic Patients Taking Part in Integrated Care Program (NCT00617214) | AstraZeneca | 2008-01-01 |
| Conversion to Antipsychotic Monotherapy (NCT01368458) | Nathan Kline Institute for Psychiatric Research | 2007-12-01 |
| A Comparison of Two Cognitive Batteries in People With Schizophrenia (NCT00499044) | North Suffolk Mental Health Association | 2007-12-01 |
| Neurophysiological Studies in Schizophrenia and Psychiatric Disorders (NCT01384604) | University of Texas Southwestern Medical Center | 2007-12-01 |
| Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia (NCT00575848) | North Suffolk Mental Health Association | 2007-12-01 |
| Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia (NCT00936351) | US Department of Veterans Affairs | 2007-12-01 |
| The Effects of Rimonabant, on Weight and Metabolic Risk Factors (NCT00547118) | University of Maryland, Baltimore | 2007-11-01 |
| An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders (NCT01855074) | Janssen-Cilag Ltd. | 2007-11-01 |
| Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia (NCT00690235) | University of Texas Southwestern Medical Center | 2007-11-01 |
| A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis (NCT00591318) | Research Foundation for Mental Hygiene, Inc. | 2007-10-10 |
| Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease (NCT00535145) | Ortho-McNeil Janssen Scientific Affairs, LLC | 2007-10-01 |
| The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. (NCT00466323) | US Department of Veterans Affairs | 2007-09-01 |
| Improving Basic and Social Cognition in Veterans With Schizophrenia (NCT00470106) | VA Office of Research and Development | 2007-09-01 |
| Complex Problem Solving Training in Schizophrenic Patients (NCT00507988) | Heidelberg University | 2007-08-01 |
| Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone (NCT00538642) | The University of Texas Health Science Center at San Antonio | 2007-08-01 |
| Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents (NCT00545467) | National Taiwan University Hospital | 2007-08-01 |
| Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment (NCT00538122) | Vanderbilt University | 2007-07-01 |
| Schizophrenia Treatment Adherence Investigation (STAI) (NCT01001481) | Janssen-Cilag Pty Ltd | 2007-07-01 |
| Cognitive Remediation and Functional Skills Training in Schizophrenia (NCT01175642) | National Alliance for Research on Schizophrenia and Depression | 2007-07-01 |
| Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine (NCT00512070) | Seattle Institute for Biomedical and Clinical Research | 2007-07-01 |
| Systematic Evaluation of Antiviral Medication in Schizophrenia (NCT00514449) | Konasale Prasad | 2007-06-01 |
| Efficacy of Pregnenolone in Patients With Schizophrenia (NCT00615511) | Weill Medical College of Cornell University | 2007-06-01 |
| Anticholinergic Burden in Schizophrenia (NCT00715377) | Centre for Addiction and Mental Health | 2007-06-01 |
| Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis (NCT00465920) | University of Cologne | 2007-05-01 |
| Health Promotion and Fitness for Younger and Older Adults With SMI (NCT02090335) | Dartmouth-Hitchcock Medical Center | 2007-05-01 |
| Seroquel Long-Term NIS for Schizophrenia Patients (NCT00523783) | AstraZeneca | 2007-05-01 |
| Donepezil Double Blind Trial for ECT Memory Disfunction (NCT00465283) | BeerYaakov Mental Health Center | 2007-05-01 |
| Varenicline Adjunctive Treatment in Schizophrenia (NCT00492349) | University of Maryland, Baltimore | 2007-05-01 |
| Integrated Care in Psychotic Disorders With Severe Mental Illness (NCT01888627) | Universitätsklinikum Hamburg-Eppendorf | 2007-05-01 |
| Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) (NCT00453609) | State University of New York - Upstate Medical University | 2007-04-01 |
| Zyprexa and Task Engagement in Schizophrenia (NCT00440843) | VA Connecticut Healthcare System | 2007-02-01 |
| Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia (NCT00407277) | Centre for Addiction and Mental Health | 2007-02-01 |
| Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone (NCT00644852) | Johnson & Johnson Taiwan Ltd | 2007-01-01 |
| Effects of Pentazocine Versus Lorazepam on Manic Symptoms (NCT00431184) | Mclean Hospital | 2007-01-01 |
| Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder (NCT00423878) | National Institute of Mental Health (NIMH) | 2007-01-01 |
| Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder (NCT00683709) | St. Joseph's Healthcare Hamilton | 2007-01-01 |